Sage Therapeutics Receives $469 Million Takeover Bid from Biogen: A Game Changer in Neurological Treatments?

In a significant development for the pharmaceutical sector, Sage Therapeutics, a leader in the field of brain health, has attracted attention with a substantial takeover offer from Biogen totaling $469 million. This unexpected bid marks a pivotal moment for Sage, known for its innovative approaches to treating neurological disorders. The proposal comes as both companies strive to enhance their portfolios and capabilities in the competitive biopharmaceutical market.

Continue reading